Sijmen de Vries
Vermogen: - $ op 31-07-2026
Vermogen: - $ op 31-07-2026
Sijmen de Vries is currently Chief Executive Officer at Pharming Intellectual Property BV, Non-Executive Director at Sylus Pharmaceuticals Ltd. since 2010, Independent Non-Executive Director at Biodexa Pharmaceuticals Plc since 2014, and Finish Partner at BioConnection BV.
Former roles include Chief Executive Officer at Morphochem AG and 4-Antibody AG, Executive Director at Pharming Group NV from 2008 to 2025, and Non-Executive Director at Biodexa Ltd. from 2004 to 2015.
Education includes a doctorate from the University of Amsterdam and an MBA from Ashridge Business School.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-03-2026 | 0 ( -.--% ) | - $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Directeur/Bestuurslid | 13-11-2014 |
Sylus Pharmaceuticals Ltd. | Directeur/Bestuurslid | 21-06-2010 |
Pharming Intellectual Property BV
Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures milking equipment | Algemeen Directeur | - |
BioConnection BV
BioConnection BV BiotechnologyHealth Technology Provides biopharmaceutical services | Corporate Officer/Principal | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| PHARMING GROUP N.V. | Algemeen Directeur | 04-03-2025 |
Midatech Ltd.
Midatech Ltd. BiotechnologyHealth Technology Engages in discovery and the development of nanomedicine pharmaceutical products | Directeur/Bestuurslid | 13-03-2015 |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Algemeen Directeur | - |
Morphochem AG
Morphochem AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs | Algemeen Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 10 |
|---|---|
Pharming Group NV
Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
Morphochem AG
Morphochem AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs | Commercial Services |
University of Amsterdam
University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Ashridge Business School
Ashridge Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioConnection BV
BioConnection BV BiotechnologyHealth Technology Provides biopharmaceutical services | Health Technology |
Midatech Ltd.
Midatech Ltd. BiotechnologyHealth Technology Engages in discovery and the development of nanomedicine pharmaceutical products | Health Technology |
Sylus Pharmaceuticals Ltd. | |
Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
Pharming Intellectual Property BV
Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures milking equipment | Producer Manufacturing |
Kies jouw editie
Alle financiële informatie op nationaal niveau